Cargando…

Efficacy and Safety of Switching from Prostaglandin Analog Therapy to Prostaglandin / Timolol Fixed Combination or Prostaglandin / Brimonidine Therapy

BACKGROUND: To compare the safety and efficacy between switching to prostaglandin/timolol fixed combination eye drops (PG/timolol FCs) and adding brimonidine to PG analogue monotherapy. METHODS: Eyes of 53 patients with primary open-angle glaucoma or ocular hypertension who were receiving PG analogu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Kenji, Masumoto, Mieko, Ishida, Kyoko, Tomita, Goji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510563/ https://www.ncbi.nlm.nih.gov/pubmed/28761569 http://dx.doi.org/10.2174/1874364101711010156

Ejemplares similares

Efficacy and Safety of Switching Prostaglandin Analog Monotherapy to Tafluprost/Timolol Fixed-Combination Therapy
por: Kitamura, Kazuyoshi, et al.
Publicado: (2018)

Comparison of Latanoprost/Timolol with Carbonic Anhydrase Inhibitor and Dorzolamide/Timolol with Prostaglandin Analog in the Treatment of Glaucoma
por: Inoue, Kenji, et al.
Publicado: (2014)

Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs
por: Lo, Jonathan S, et al.
Publicado: (2016)

Ocular hypotensive effect, preservation of visual fields, and safety of adding dorzolamide to prostaglandin therapy for twelve months
por: Inoue, Kenji, et al.
Publicado: (2011)

Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from β-blockers and prostaglandin analogs
por: Inoue, Kenji, et al.
Publicado: (2012)

Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy
por: Hasebe, Yuka, et al.
Publicado: (2018)

Short-Term Efficacy and Safety of Switching from a Latanoprost/Timolol Fixed Combination to a Latanoprost/Carteolol Fixed Combination
por: Inoue, Kenji, et al.
Publicado: (2020)

Efficacy and Safety of Switching from Tafluprost to a Tafluprost/Timolol Fixed Combination in Patients With Primary Open-Angle Glaucoma
por: Inoue, Kenji, et al.
Publicado: (2018)

Lactones in the Synthesis of Prostaglandins and Prostaglandin Analogs
por: Tănase, Constantin, et al.
Publicado: (2021)

Efficacy and safety of travoprost 0.004%/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapy
por: Costa, Vital Paulino, et al.
Publicado: (2012)

Safety and Efficacy of Adding Fixed-Combination Brinzolamide/Timolol Maleate to Prostaglandin Therapy for Treatment of Ocular Hypertension or Glaucoma
por: Hommer, Anton, et al.
Publicado: (2015)

Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma
por: Yoshikawa, Keiji, et al.
Publicado: (2021)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
por: Inoue, Kenji, et al.
Publicado: (2015)

Randomized trial comparing three fixed combinations of prostaglandins/prostamide with timolol maleate
por: Kelly Rigollet, Jaime Pablo, et al.
Publicado: (2011)

Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial
por: Fechtner, R D, et al.
Publicado: (2016)

Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension
por: Topouzis, Fotis, et al.
Publicado: (2019)

Prostaglandin analogs in ophthalmology
por: Subbulakshmi, S, et al.
Publicado: (2023)

Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
por: Inatani, Masaru, et al.
Publicado: (2023)

Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin‐treated glaucoma patients
por: Aihara, Makoto, et al.
Publicado: (2017)

Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden
por: Bergström, Anders, et al.
Publicado: (2009)

Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog
por: Shimizu, Yoshie, et al.
Publicado: (2015)

Conjunctival changes and inflammatory aspects in rabbits' conjunctivas induced by fixed combinations of prostaglandin analogues and timolol maleate
por: de Faria, Nubia Vanessa Lima, et al.
Publicado: (2013)

Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients
por: Horsley, Michael B, et al.
Publicado: (2009)

Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs
por: Schmier, Jordana K, et al.
Publicado: (2014)

Prostaglandins and prostaglandin receptor antagonism in migraine
por: Antonova, M
Publicado: (2013)

Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months
por: Inoue, Kenji, et al.
Publicado: (2014)

Prostaglandins
por: Kotchen, Theodore A.
Publicado: (1968)

Switching from concomitant therapy to tafluprost/timolol fixed combination
por: Inoue, Kenji, et al.
Publicado: (2018)

Switching patients from preserved prostaglandin-analog monotherapy to preservative-free tafluprost
por: Hommer, Anton, et al.
Publicado: (2011)

Addition of a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension
por: Lorenz, Katrin, et al.
Publicado: (2011)

Safety comparison of additives in antiglaucoma prostaglandin (PG) analog ophthalmic formulations
por: Fukuda, Masamichi, et al.
Publicado: (2013)

Prostaglandin research /
Publicado: (1977)

Prostaglandins and Cancer
por: Moore, K.
Publicado: (1983)

Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost
por: Fechtner, Robert D, et al.
Publicado: (2011)

Initial Treatment: Prostaglandin Analog or Selective Laser Trabeculoplasty
por: Clement, Colin I
Publicado: (2012)

Periorbital changes associated with prostaglandin analogs in Korean patients
por: Kim, Hee Weon, et al.
Publicado: (2017)

A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure
por: Hartleben, Curt, et al.
Publicado: (2017)

Tolerability in Glaucoma Patients Switched from Preserved to Preservative-Free Prostaglandin-Timolol Combination: A Prospective Real-Life Study
por: Jandroković, Sonja, et al.
Publicado: (2022)

Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy
por: Wang, Qiushi, et al.
Publicado: (2022)

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
por: Inoue, Kenji, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6gpe05qslv9hltdjn6lp3n95jp